Results 201 to 210 of about 588,306 (330)

Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Endocr Rev, 2016
Di Jeso B, Arvan P.
europepmc   +1 more source

Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor Agonists

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‑1 RAs) play a pivotal role in treating type 2 diabetes. Despite their widespread use, their dermatological manifestations remain under‐recognized, hence the interest of this systematic review. Objectives This systematic review aims to assess dermatological manifestations associated with
Nour Ghostine, Maya Halabi‐Tawil
wiley   +1 more source

Genetic Testing in Clinical Endocrinology [PDF]

, 2003
Constantin Polychronakos
openalex   +1 more source

Improving Medical‐Dental Integration Through Inter‐Provincial, Inter‐Professional Collaboration

Journal of Dental Education, EarlyView.
Ishita Patel, Minn N. Yoon, Nassrein Hussein, Amrinderbir Singh   +3 more
wiley   +1 more source

Vitexin Attenuates the Growth and Glycolysis of Acute Myeloid Leukemia Cells by Suppressing the HIF‐1α‐Modulated YAP Pathway Under Hypoxic Conditions

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Vitexin, an apigenin flavone glycoside, exhibits antitumor activity against various cancers including leukemia. Hypoxia enhances glycolysis, thereby promoting tumor growth. In this study, we aimed to explore the effects of vitexin on hypoxia‐induced growth and glycolysis in acute myeloid leukemia (AML) cells and determine the underlying ...
Ping Wang, Jia‐Jia Zhang, Fang Zhang, Xiao‐Jie Qu, Hui Zhang   +4 more
wiley   +1 more source

Clinical Endocrinology [PDF]

Journal of Clinical Pathology, 1972
openaire   +1 more source

Free Communications of the Gulf Association of Endocrinology and Diabetes Clinical Congress, October 18–20, 2024, Abu Dhabi, United Arab Emirates [PDF]

Wiam I. Hussein, Thamer Alessa, Ali Al-Risi, Bachar Afandi, Raya Almazrouei, Naji Aljohani   +5 more
openalex   +1 more source

Translational Highlights from The Journal of Clinical Endocrinology & Metabolism [PDF]

, 2011
J Li, Y Ge, Z Yang, C Guo, T Duan, L Myatt, H Guan, K Yang, K Sun, Tetsuya Tagami, Takeshi Usui, Akira Shimatsu, Mutsuo Beniko, Hiroyuki Yamamoto, Kenji Moriyama, Mitsuhide Naruse, Hong Jiao, Peter Arner, Suzanne Dickson, Hubert Vidal, Niklas Mejhert, Corneliu Henegar, Magdalena Taube, Caroline Hansson, Anke Hinney, Pilar Galan, Chantal Simon, Angela Silveira, Anna Benrick, John-Olov Jansson, Anne Bouloumie, Dominique Langin, Martine Laville, Cyrille Debard, Tomas Axelsson, Mikael Ryde, Juha Kere, Karin Dahlman-Wright, Anders Hamsten, Karine Clement, Ingrid Dahlman   +40 more
openalex   +1 more source

Personalized AZithromycin/metronidAZole + dietary therapy in pediatric Crohn disease: Results of a pilot study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Charlotte M. Verburgt, Nikki van der Kruk, Katherine A. Dunn, PAZAZ‐study investigators, Charlotte M. Verburgt, Nikki van der Kruk, Katherine A. Dunn, Joseph P. Bielawski, Anthony R. Otley, Tim de Meij, Francisco Sylvester, Andre M. Comeau, Morgan G. I. Langille, Wouter J de Jonge, Johan E. Van Limbergen, Johan E. Van Limbergen   +15 more
wiley   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao, Jing Zhou, Jing Wang, Si‐Nan Zhao, Zhan‐Sheng Zhao, Qian Wang, Ya‐Nan Xie, Wei Jiao   +7 more
wiley   +1 more source